Two polyhydroxylated Δ 13 -17,17-dialkyl-18-norsteroids were prepared by BF 3 ·Et 2 O/Ac 2 O-promoted regioselective E-ring cleavage/ 1-2 hydride shift/ Wagner-Meerwein rearrangement of furostanols derived from the steroid sapogenins diosgenin and sarsasapogenin. Details of the spectroscopic characterization are discussed. Furostanols derived from the reductive cleavage of the F-ring of steroid sapogenins are being extensively employed as starting materials in our ongoing project on the synthesis of different families of potential bioactive steroids [4]. With this information, we decided to set up conditions for the preparation of the title compounds using steroid sapogenins as starting materials. Herein we report on the synthesis and characterization of polyhydroxylated 17β-methyl-Δ 13 -18-norsteroids by BF 3 ·Et 2 O /Ac 2 O-promoted regioselective E-ring cleavage of furostanols, followed by 1-2 hydride shift and Wagner-Meerwein rearrangement.
Wagner-Meerwein rearrangements to 17β-methyl-17α-substituted-Δ 13 -18-norsteroids have been observed on the dehydration of 17α-methyl-17β-hydroxysteroids under the acidic conditions that prevail in the stomach [1a] . The same rearrangement has been produced on 17α-methyl-17β-hydroxyandrostane sulfates in aqueous media [1b] , and by attempts at derivatization of 17α-methyl-17β-hydroxysteroids Acid catalyzed cleavage of tetrahydrofurans is a useful tool for the preparation οf 4-halobutyl carboxylates [2] . This type of cleavage reaction has also been reported in the steroid field and may, in some cases [3] , be accompanied by rearrangements produced by the migration of an adjacent group [3a] .
Furostanols derived from the reductive cleavage of the F-ring of steroid sapogenins are being extensively employed as starting materials in our ongoing project on the synthesis of different families of potential bioactive steroids [4] . With this information, we decided to set up conditions for the preparation of the title compounds using steroid sapogenins as starting materials. Herein we report on the synthesis and characterization of polyhydroxylated 17β-methyl-Δ 13 -18-norsteroids by BF 3 ·Et 2 O /Ac 2 O-promoted regioselective E-ring cleavage of furostanols, followed by 1-2 hydride shift and Wagner-Meerwein rearrangement.
Furostanols can be prepared easily from steroid sapogenins using different methods [4, 5] . Treatment of diosgenin (1a) or sarsasapogenin (1b) with NaCNBH 3 in AcOH/CH 2 Cl 2 afforded the corresponding furostanols 2a and 2b in good yields (Scheme 1). The R-configuration of the stereogenic center at C-22 has been previously corroborated in nOe-difference experiments [4] The spectral data obtained are in good agreement with the proposed structures of the rearranged products. Characteristic of 17,17-dialkyl-Δ 13 -18-norsteroids [1c] , the mass spectra of the rearranged triacetates (3a and 3b) show molecular ions of very low intensity (less than 1%), from which the largest alkyl fragment is lost to give place to an allylic carbocation as the most abundant peak (Scheme 2). Similar fragmentations, but with a more abundant molecular ion, were observed for triols 4a and 4b. Scheme 2.
In the 1 H NMR spectra, the absence of the deshielded H-16 multiplet, the downfield shift of the signals corresponding to H-22, and the migrated methyl group, together with the upfield shift of H-21 characterize the obtained structures.
In addition to the two new deshielded 13 C signals of C-13 and C-14 that evidence the presence of two new sp2 carbons, the 13 C NMR spectra of the rearranged products (3a and 3b) and the corresponding triols (4a and 4b) show strong upfield shifts in the signals of C-16 (no longer attached to an oxygen atom), C-17 (now quaternary) and the carbinolic C-22 (no longer part of a tetrahydrofuran ring). Additionally, the downfield shift in the signals of C-20 and the migrated methyl group (now attached to C-17) add evidence to the transformations effected. The presence of a highly shielded signal corresponding to Me-21 also characterizes the proposed structures.
In summary, two new 17β-methyl-Δ 13 -18-norsteroids have been prepared using a tandem process that includes BF 3 ·Et 2 O/Ac 2 O-promoted regioselective E-ring cleavage of furostanols, followed by a 1-2 hydride shift and Wagner-Meerwein rearrangement. Sodium cyanoborohydride (132 mg, 2 mmol) was added to a solution of (25R)-spirost-5-en-3β-ol (diosgenin, 1a), (414 mg, 1 mmol) in a mixture of acetic acid (5 mL) and CH 2 Cl 2 (2 mL) and the mixture was stirred for 24 hours before pouring into water and extraction with ethyl acetate (3x10 mL). The organic layer was washed with water and, very carefully, with small portions of 5% Na 2 CO 3 solution (until the evolution of CO 2 ceased) and brine (3x 10 mL), dried (anhyd. Na 2 SO 4 ) and evaporated to afford, after flash chromatography, 353 mg (0.85 mmol, 85%) of the furostanol 2a.
Experimental
MP: 156-158ºC from ethyl acetate-n-hexane. 16 (22R, 25R)-17β-Methyl-18-norcholest-5,13-dien-3β, 22,26-triol triacetate (3a) BF 3 .Et 2 O (1 mL) was added to a suspension of 417 mg (1 mmol) of the furostanol 2a in Ac 2 O (5 mL). The mixture was stirred for 20 min., poured into crushed ice, allowed to stand until the ice had melted and extracted with ethyl acetate (3x10 mL). The organic layer was washed with water and, very carefully, with Na 2 CO 3 (until the evolution of CO 2 ceased) and brine (3x10 mL), dried (anhyd. Na 2 SO 4 ) and evaporated to afford, after flash chromatography, 434 mg (0.81 mmol, 81%) of the rearranged syrupy product 3a.
1 H NMR (300 MHz, CDCl 3 ): 5.44 (1H, d, J = 4.5 Hz, H-5), 5.08 (1H, dt, J = 10.7 Hz. H-22), 4.61 (1H, m, H-3), 3.88 (2H, dd, J = 3.6, 6.2 Hz, H-26), 2.18 (3H, s, CH 3 acetate), 2.06 (3H, s, CH 3 acetate), 2.04 (3H, s, CH 3 acetate), 1.09 (3H, s, CH 3 -17´), 0.99 (3H, s, CH 3 -19), 0.92 (3H, d, J = 6.7 Hz, CH 3 -27), 0.77 (3H, d, J = 7.1 Hz, CH 3 -21). 13 C NMR (75.5 MHz CDCl 3 ): 36.9 C-1; 27.5 C-2; 74.0 C-3; 37.9 C-4; 140.2 C-5; 122.6 C-6; 32.1 C-7; 33.0 C-8; 48.9 C-9; 36.7 C-10; 26. 8 C-11; 22.8 C-12; 140.0 C-13; 136.8 C-14; 32.8 C-15 23.2 C-16; 51.7 C-17; 25.2 C-17´; 18.5 C-19; 42.1 C-20; 9.7 C-21; 75.5 C-22; 31.3 C-23; 29.8 C-24; 32.3 C-25; 69.2 C-26; 16.7 C-27; 171.1, 170.6 and 170.5 C=O acetate; 21.4, 21.34 and 20.9 171.2, 170.7 and 170.6 C=O acetate; 21.5, 21.3 and 20.9 CH 3 
A solution of 542 mg (1 mmol) of the triacetate 3a in 20 mL of 5% KOH-MeOH was refluxed for 8 hours.
After conclusion of the reaction, saturated NaCl solution (20 mL) was added, most of the methanol was evaporated and the product was extracted with ethyl acetate (3x30 mL). The combined extracts were washed with water (3x25 mL) and brine (2x15 mL), then dried (anhyd. Na 2 SO 4 ) and evaporated to afford 409 mg (98%) of the triol 4a. : 192-194ºC -5; 122.7 C-6; 32.2 C-7; 34.8 C-8; 50.9 C-9; 38.2 C-10; 24.7 C-11; 24.4 C-12; 142.0 C-13; 138.1 C-14; 32.8 C-15; 30.7 C-16; 53 13 C NMR (75.5 MHz CDCl 3 ): 30.9 C-1; 27.2 C-2; 67.6 C-3; 31.7 C-4; 37. 5 C-5; 28.4 C-6; 28.6 C-7; 38.6 C-8; 39.1 C-9; 36.2 C-10; 24.7 C-11; 24.3 C-12; 141.1 C-13; 139.10 C-14; 34.5 C-15; 31.0 C-16; 53.1 C-17; 26.1 C-17´; 24.0 C-19; 47.0 C-20; 10.7 C-21; 73.9 C-22; 34.5 C-23; 32.1 C-24; 37.3 C-25; 68.2 C-26; 17.7 C-27 
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